Literature DB >> 18710865

Identification and characterization of the Plasmodium yoelii PyP140/RON4 protein, an orthologue of Toxoplasma gondii RON4, whose cysteine-rich domain does not protect against lethal parasite challenge infection.

David L Narum1, Vu Nguyen, Yanling Zhang, Jacqueline Glen, Richard L Shimp, Lynn Lambert, Irene T Ling, Karine Reiter, Solabomi A Ogun, Carole Long, Anthony A Holder, Raul Herrera.   

Abstract

Previously, we identified a Plasmodium yoelii YM 140-kDa merozoite protein, designated PyP140, which formed a complex with apical membrane antigen 1 (AMA1). Furthermore, we produced a nonprotective monoclonal antibody (MAb), 48F8, that immunoprecipitated metabolically labeled PyP140 and localized the protein to the merozoite's apical end and, less frequently, to the merozoite surface, as observed by immunofluorescence assay (IFA). Here, using MAb 48F8, we have identified the pyp140 gene by screening a P. yoelii lambda-Zap cDNA expression library. The pyp140 cDNA covers approximately 90% of the putative open reading frame (ORF) of PY02159 from the P. yoelii NL genome sequencing project. Analysis of the complete gene identified the presence of two introns. The ORF encodes a 102,407-Da protein with an amino-terminal signal sequence, a series of three unique types of repeats, and a cysteine-rich region. The binding site of MAb 48F8 was also identified. A BLAST search with the deduced amino acid sequence shows significant similarity with the Toxoplasma gondii RON4 protein and the Plasmodium falciparum RON4 protein, and the sequence is highly conserved in other Plasmodium species. We produced the cysteine-rich domain of PyP140/RON4 by using the Pichia pastoris expression system and characterized the recombinant protein biochemically and biophysically. BALB/c mice immunized with the protein formulated in oil-in-water adjuvants produced antibodies that recognize parasitized erythrocytes by IFA and native PyP140/RON4 by immunoblotting but failed to protect against a lethal P. yoelii YM infection. Our results show that PyP140/RON4 is located within the rhoptries or micronemes. It may associate in part with AMA1, but the conserved cysteine-rich domain does not appear to elicit inhibitory antibodies, a finding that is supported by the marked sequence conservation in this protein within Plasmodium spp., suggesting that it is not under immune pressure.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18710865      PMCID: PMC2573347          DOI: 10.1128/IAI.01717-07

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  Sudden increase in virulence in a strain of Plasmodium berghei yoelii.

Authors:  M Yoeli; B Hargreaves; R Carter; D Walliker
Journal:  Ann Trop Med Parasitol       Date:  1975-06

2.  Vaccination trials in rhesus monkeys with a minor, invariant, Plasmodium knowlesi 66 kD merozoite antigen.

Authors:  J A Deans; A M Knight; W C Jean; A P Waters; S Cohen; G H Mitchell
Journal:  Parasite Immunol       Date:  1988-09       Impact factor: 2.280

3.  Erythrocyte-binding activity of Plasmodium yoelii apical membrane antigen-1 expressed on the surface of transfected COS-7 cells.

Authors:  T S Fraser; S H Kappe; D L Narum; K M VanBuskirk; J H Adams
Journal:  Mol Biochem Parasitol       Date:  2001-09-28       Impact factor: 1.759

4.  Rat monoclonal antibodies which inhibit the in vitro multiplication of Plasmodium knowlesi.

Authors:  J A Deans; T Alderson; A W Thomas; G H Mitchell; E S Lennox; S Cohen
Journal:  Clin Exp Immunol       Date:  1982-08       Impact factor: 4.330

5.  Vaccination of monkeys with recombinant Plasmodium falciparum apical membrane antigen 1 confers protection against blood-stage malaria.

Authors:  Anthony W Stowers; Michael C Kennedy; Brian P Keegan; Allan Saul; Carole A Long; Louis H Miller
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

6.  Phase 1 clinical trial of apical membrane antigen 1: an asexual blood-stage vaccine for Plasmodium falciparum malaria.

Authors:  Elissa M Malkin; David J Diemert; Julie H McArthur; John R Perreault; Aaron P Miles; Birgitte K Giersing; Gregory E Mullen; Andrew Orcutt; Olga Muratova; May Awkal; Hong Zhou; Jin Wang; Anthony Stowers; Carole A Long; Siddhartha Mahanty; Louis H Miller; Allan Saul; Anna P Durbin
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

7.  Toxoplasma gondii homologue of plasmodium apical membrane antigen 1 is involved in invasion of host cells.

Authors:  A B Hehl; C Lekutis; M E Grigg; P J Bradley; J F Dubremetz; E Ortega-Barria; J C Boothroyd
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

8.  Apical membrane antigen 1, a major malaria vaccine candidate, mediates the close attachment of invasive merozoites to host red blood cells.

Authors:  G H Mitchell; A W Thomas; G Margos; A R Dluzewski; L H Bannister
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

9.  The Fab fragments of monoclonal IgG to a merozoite surface antigen inhibit Plasmodium knowlesi invasion of erythrocytes.

Authors:  A W Thomas; J A Deans; G H Mitchell; T Alderson; S Cohen
Journal:  Mol Biochem Parasitol       Date:  1984-10       Impact factor: 1.759

10.  Immunization with parasite-derived apical membrane antigen 1 or passive immunization with a specific monoclonal antibody protects BALB/c mice against lethal Plasmodium yoelii yoelii YM blood-stage infection.

Authors:  D L Narum; S A Ogun; A W Thomas; A A Holder
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

View more
  17 in total

1.  Immunomic Identification of Malaria Antigens Associated With Protection in Mice.

Authors:  Anthony Siau; Ximei Huang; Han Ping Loh; Neng Zhang; Wei Meng; Siu Kwan Sze; Laurent Renia; Peter Preiser
Journal:  Mol Cell Proteomics       Date:  2019-02-04       Impact factor: 5.911

2.  Peptide inhibitors of the malaria surface protein, apical membrane antigen 1: identification of key binding residues.

Authors:  Erinna F Lee; Shenggen Yao; Jennifer K Sabo; W Douglas Fairlie; Rachel A Stevenson; Karen S Harris; Robin F Anders; Michael Foley; Raymond S Norton
Journal:  Biopolymers       Date:  2011-01-06       Impact factor: 2.505

3.  Total and putative surface proteomics of malaria parasite salivary gland sporozoites.

Authors:  Scott E Lindner; Kristian E Swearingen; Anke Harupa; Ashley M Vaughan; Photini Sinnis; Robert L Moritz; Stefan H I Kappe
Journal:  Mol Cell Proteomics       Date:  2013-01-16       Impact factor: 5.911

4.  Identification and Characterization of the Rhoptry Neck Protein 2 in Babesia divergens and B. microti.

Authors:  Rosalynn L Ord; Marilis Rodriguez; Jeny R Cursino-Santos; Hyunryung Hong; Manpreet Singh; Jeremy Gray; Cheryl A Lobo
Journal:  Infect Immun       Date:  2016-04-22       Impact factor: 3.441

5.  Interaction between Plasmodium falciparum apical membrane antigen 1 and the rhoptry neck protein complex defines a key step in the erythrocyte invasion process of malaria parasites.

Authors:  Dave Richard; Christopher A MacRaild; David T Riglar; Jo-Anne Chan; Michael Foley; Jake Baum; Stuart A Ralph; Raymond S Norton; Alan F Cowman
Journal:  J Biol Chem       Date:  2010-03-12       Impact factor: 5.157

6.  Structure of the Plasmodium falciparum circumsporozoite protein, a leading malaria vaccine candidate.

Authors:  Matthew L Plassmeyer; Karine Reiter; Richard L Shimp; Svetlana Kotova; Paul D Smith; Darrell E Hurt; Brent House; Xiaoyan Zou; Yanling Zhang; Merrit Hickman; Onyinyechukwu Uchime; Raul Herrera; Vu Nguyen; Jacqueline Glen; Jacob Lebowitz; Albert J Jin; Louis H Miller; Nicholas J MacDonald; Yimin Wu; David L Narum
Journal:  J Biol Chem       Date:  2009-07-24       Impact factor: 5.157

7.  The RON2-AMA1 interaction is a critical step in moving junction-dependent invasion by apicomplexan parasites.

Authors:  Mauld Lamarque; Sébastien Besteiro; Julien Papoin; Magali Roques; Brigitte Vulliez-Le Normand; Juliette Morlon-Guyot; Jean-François Dubremetz; Sylvain Fauquenoy; Stanislas Tomavo; Bart W Faber; Clemens H Kocken; Alan W Thomas; Martin J Boulanger; Graham A Bentley; Maryse Lebrun
Journal:  PLoS Pathog       Date:  2011-02-10       Impact factor: 6.823

8.  Targeted disruption of py235ebp-1: invasion of erythrocytes by Plasmodium yoelii using an alternative Py235 erythrocyte binding protein.

Authors:  Solabomi A Ogun; Rita Tewari; Thomas D Otto; Steven A Howell; Ellen Knuepfer; Deirdre A Cunningham; Zhengyao Xu; Arnab Pain; Anthony A Holder
Journal:  PLoS Pathog       Date:  2011-02-17       Impact factor: 6.823

9.  An inhibitory antibody blocks interactions between components of the malarial invasion machinery.

Authors:  Christine R Collins; Chrislaine Withers-Martinez; Fiona Hackett; Michael J Blackman
Journal:  PLoS Pathog       Date:  2009-01-23       Impact factor: 6.823

10.  Subcompartmentalisation of proteins in the rhoptries correlates with ordered events of erythrocyte invasion by the blood stage malaria parasite.

Authors:  Elizabeth S Zuccala; Alexander M Gout; Chaitali Dekiwadia; Danushka S Marapana; Fiona Angrisano; Lynne Turnbull; David T Riglar; Kelly L Rogers; Cynthia B Whitchurch; Stuart A Ralph; Terence P Speed; Jake Baum
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.